65,437 trials
Opioid Use · Pain, Postoperative
Primary: Pain Level — 12.3; 15.9 millimeters on a scale
Abdominal Pain
Primary: Gallbladder Ejection Fraction — 15 percentage of ejection of tracer
Papillomavirus Infections · Warts · Condylomata Acuminata
Primary: Difference in % Reduction in Wart Size Between Product A and Product B at Each Timepoint
Other Abortion · Spontaneous Abortion
Primary: Pain Score on 100-mm VAS (Visual Analog Scale) at 5 Minutes Post-procedure — 35.7; 37.1 score on a scale — p=0.56
Chronic Idiopathic Constipation
Primary: Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE) — 123; 620 Participants
Healthy
Primary: Oxygen Saturation (SpO2) Accuracy of Sensor by Arms Calculation During Non-motion — 1.33 % of oxygen saturated hemoglobin
Cocaine Use Disorder
Primary: Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative — .34; .24; 4.31; 3.9 Cocaine Choices
Breast Enhancement
Primary: Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment — 48 Breasts
Epidermolysis Bullosa · Pruritus
Primary: Comparative Weekly Change in NRS Itch Score Over the 8-week Active Treatment Period — -2; -1 score/week comparative change
Laparoscopic Herniotomy
Primary: Improvement of Surgical Workspace — 0; 1; 0; 0 Participants
Post Traumatic Stress Disorder
Primary: CAPS-IV at the End of Treatment — 52.42; 50.61; 54.20; 48.59 units on a scale
Obesity · Fatty Liver, Nonalcoholic
Primary: Insulin-stimulated Glucose Uptake — 5.9; 5.9 mg/kg/minute
Cytomegalovirus Infection
Primary: Incidence of Cytomegalovirus (CMV) Disease. — 9; 20 participants — p=0.0396
Irritable Bowel Syndrome
Primary: Within and Between Group Comparisons of Disease Severity as Determined by Irritable Bowel Syndrome-Symptom Severity Score (IBS-SSS) — 282; 309; 221; 236 units on a scale
Migraine
Primary: Headache Severity — 2.00; 2.00 score on a scale